Cardio-ankle Vascular Index (CAVI) in Hypertension Patients After One Year of Treatment

Overview

This study aimed to evaluate the role of the cardio-ankle vascular index (CAVI) in evaluating arterial stiffness changes, the degree of atherosclerosis in patients with hypertension after 1 year of treatment and analysis the correlation between CAVI and cardiovascular risk factors.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: June 1, 2017

Interventions

  • Procedure: Hypertension outpatient treatment
    • Patients who have been diagnosed with primary hypertension and meet the conditions of the study will receive outpatient treatment

Arms, Groups and Cohorts

  • Hypertension group
    • All adult patients (above 18 year of age) were recruited between May, 2016 and June 2017, at Duc Giang General Hospital. The inclusion criteria are as followed: Patients have never been diagnosed with hypertension. Has been diagnosed with primary hypertension, but not take any treatment.
  • Control group
    • A group of normal people with the similar age to hypertension group was recruited as control group at the same time

Clinical Trial Outcome Measures

Primary Measures

  • CAVI score in hypertension group after one year of treatment
    • Time Frame: 1 year
    • CAVI score of patients who achieved their target blood pressure after one year of hypertension treatment

Secondary Measures

  • Correlation between CAVI and smoking status
    • Time Frame: 1 year
    • Evaluating correlation between CAVI score and smoking status in hypertension patients
  • Correlation between CAVI and overweight status
    • Time Frame: 1 year
    • Evaluating correlation between CAVI score and overweight status in hypertension patients
  • Correlation between CAVI and diabetes status
    • Time Frame: 1 year
    • Evaluating correlation between CAVI score and diabetes status in hypertension patients
  • Correlation between CAVI and dislypidemia status
    • Time Frame: 1 year
    • Evaluating correlation between CAVI score and dyslipidemia status in hypertension patients

Participating in This Clinical Trial

Inclusion Criteria

  • Patients have never been diagnosed with hypertension.
  • Patients have been diagnosed with primary hypertension, but not take any treatment

Exclusion Criteria

  • Cases with non-primary hypertension or suffering from cardiovascular complications such as myocardial infarction, cerebral stroke, vascular disease, severe heart failure (EF<1) in the time of measurement.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Hanoi Medical University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Bui My Hanh, Director, Science Research and International Cooperation Unit – Hanoi Medical University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.